Stay updated on Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.4 was added and v3.5.3 was removed, indicating a minor page/template update to the entry that does not modify the study data.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s footer revision label is updated from **v3.5.2** to **v3.5.3**, indicating a site software/version refresh rather than a change to the clinical trial record.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check65 days agoChange DetectedPage revision updated to v3.4.3, replacing v3.4.2. No changes to study details or content are visible.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page shows Revision: v3.4.2 and a funding/status notice was removed. These are administrative updates that do not affect study data, eligibility criteria, outcomes, or how users interact with the page.SummaryDifference0.4%

Stay in the know with updates to Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.